DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-01-31
DOI
10.3389/fendo.2018.00014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles
- (2017) Xue-Li Li et al. MEDICINE
- Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis
- (2017) Kevin N Keane et al. BMJ Open
- Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial
- (2016) Mohamed M.M. Kotb et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Effect of dehydroepiandrosterone administration in Chinese women over 37 years undergoing assisted reproductive techniques
- (2016) Xuemei Liu et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial
- (2016) Yasmin Ahmed Bassiouny et al. FERTILITY AND STERILITY
- Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis
- (2016) Meixiang Zhang et al. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
- PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome
- (2016) John Yovich et al. Drug Design Development and Therapy
- A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders
- (2015) TWY Yeung et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response
- (2015) Yomna A. Bayoumi et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Dehydroepiandrosterone decreases the age-related decline of the in vitro fertilization outcome in women younger than 40 years old
- (2015) Massimo Tartagni et al. Reproductive Biology and Endocrinology
- Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study
- (2015) Nikos Vlahos et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Mid-luteal serum progesterone concentrations govern implantation rates for cryopreserved embryo transfers conducted under hormone replacement
- (2015) John L. Yovich et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization
- (2015) Kevin Keane et al. Drug Design Development and Therapy
- Effect of Dehydroepiandrosterone Administration in Patients with Poor Ovarian Response According to the Bologna Criteria
- (2014) Bei Xu et al. PLoS One
- British Fertility Society Policy and Practice Committee: Adjuvants in IVF: Evidence for good clinical practice
- (2014) Luciano G. Nardo et al. Human Fertility
- Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in vitro fertilization: a randomized controlled trial
- (2014) Huan H Zhang et al. Journal of Ovarian Research
- Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis
- (2013) Amarin Narkwichean et al. Reproductive Biology and Endocrinology
- Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology
- (2012) Maryam Eftekhar et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
- (2011) A. P. Ferraretti et al. HUMAN REPRODUCTION
- Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)
- (2011) Norbert Gleicher et al. Reproductive Biology and Endocrinology
- Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis
- (2011) Sesh Kamal Sunkara et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Targeted gonadotrophin stimulation using the PIVET algorithm markedly reduces the risk of OHSS
- (2011) John Yovich et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: A randomized prospective study
- (2010) A. Wiser et al. HUMAN REPRODUCTION
- Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)
- (2010) Norbert Gleicher et al. Reproductive Biology and Endocrinology
- Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF
- (2010) John L. Yovich et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis
- (2009) E.M. Kolibianakis et al. HUMAN REPRODUCTION UPDATE
- How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis
- (2008) Dimitra Kyrou et al. FERTILITY AND STERILITY
- Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure
- (2007) Jeffrey D. Fisch et al. FERTILITY AND STERILITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started